Specificity for human disease

26 February 2024

In this video, Olink® highlights a three-step, 15-factor analytical verification process for reducing inaccuracies of protein detection for human disease studies. Olink's dual-recognition, DNA-coupled technology delivers industry-leading specificity, eliminating wrong targets, misinterpretation and wasted resources. Every assay undergoes a rigorous validation process, ensuring quality data.